• AbCellera and Novartis enter into multi-target partnership pharmaceutical-technology
    February 15, 2019
    Canada-based AbCellera has announced it has signed a multi-year, multi-target agreement with Novartis under which its antibody discovery technology will be leveraged by the Swiss pharma giant for up to ten clinically-relevant disease targets....
PharmaSources Customer Service